Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Wu, Ming; Gu, Junhui; Mei, Shuqin; Xu, Dechao; Jing, Ying; Yao, Qing; Chen, Meihan; Yang, Ming; Chen, Sixiu; Yang, Bo; Qi, Na; Hu, Huimin; Wüthrich, Rudolf P; Mei, Changlin (2016). Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation. Nephrology, Dialysis, Transplantation, 31(11):1826-1834.

Wu, Ming; Chen, Meihan; Jing, Ying; Gu, Junhui; Mei, Shuqin; Yao, Qing; Zhou, Jie; Yang, Ming; Sun, Lijun; Wang, Wutao; Hu, Huimin; Wüthrich, Rudolf P; Mei, Changlin (2016). The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology, 310(11):1284-1294.

Gu, Junhui; Yang, Ming; Qi, Na; Mei, Shuqin; Chen, Jiejian; Song, Shuwei; Jing, Ying; Chen, Meihan; He, Liangliang; Sun, Lijun; Hu, Huimin; Li, Lin; Wüthrich, Rudolf P; Wu, Ming; Mei, Changlin (2016). Olmesartan prevents microalbuminuria in db/db diabetic mice through inhibition of angiotensin II/p38/SIRT1-induced podocyte apoptosis. Kidney & Blood Pressure Research, 41(6):848-864.

Rodriguez, Daniel; Kapoor, Sarika; Edenhofer, Ilka; Segerer, Stephan; Riwanto, Meliana; Kipar, Anja; Yang, Ming; Mei, Changlin; Wüthrich, Rudolf P (2015). Inhibition of Sodium-GlucoseCotransporter 2 with dapagliflozin in Han: SPRD rats with polycystic kidney disease. Kidney & Blood Pressure Research, 40(6):638-647.

This list was generated on Thu Apr 18 22:29:49 2019 CEST.